Latest News about VIR
Recent news which mentions VIR
Stocks That Hit 52-Week Lows On Monday
February 28, 2022
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 23, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
3 Biotech Stocks That Are too Cheap to Ignore
February 10, 2022
From Motley Fool
From Benzinga
Immunome Shares Seesaw After COVID-19 Antibody Cocktail Works Against Live Omicron Virus
February 08, 2022
From Benzinga
From Benzinga
‘You will not believe what I’ve just found.’ Inside the ivermectin saga: a hacked password, mysterious websites and faulty data
February 07, 2022
From MarketWatch
COVID-19 treatments raked in billions of dollars in 2021. How will they do this year?
February 04, 2022
From MarketWatch
South Africa study shows boosters failed to block omicron, bolstering case for face masks, distancing and hand washing
January 20, 2022
From MarketWatch
2 Best COVID-19 Growth Stocks to Own in 2022
January 17, 2022
From Motley Fool
From Benzinga
2 Top Healthcare Stocks to Buy Right Now
January 14, 2022
From Motley Fool
GSK, Vir Biotech File For Emergency Use Nod For Intramuscular Sotrovimab For COVID-19
January 13, 2022
From Benzinga
Adagio's COVID-19 Antibody Has Neutralizing Activity Comparable To Other Antibodies
January 13, 2022
From Benzinga
20 Stocks Moving in Thursday's Pre-Market Session
January 13, 2022
From Benzinga
50 Biggest Movers From Yesterday
January 13, 2022
From Benzinga
From Benzinga
From MarketWatch
My 3 Top Biotech Stock Picks for 2022
January 09, 2022
From Motley Fool
3 COVID Stocks That Will Make Billions in 2022
January 07, 2022
From Motley Fool
Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
December 29, 2021
From Benzinga
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
December 26, 2021
From Benzinga
55 Biggest Movers From Yesterday
December 22, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.